These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26141018)

  • 1. The role of immunohistochemistry in the evaluation of gynecologic pathology part 2: a comparative study between two academic institutes.
    Desouki MM; Chamberlain BK; Li Z
    Ann Diagn Pathol; 2015 Oct; 19(5):296-300. PubMed ID: 26141018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immunohistochemistry in the evaluation of gynecologic pathology: a single institutional experience.
    Chamberlain BK; Fadare O; Desouki MM
    Ann Diagn Pathol; 2015 Apr; 19(2):88-90. PubMed ID: 25616744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic Analysis in Early Müllerian Serous Carcinogenesis.
    Nafisi H; Ghorab Z; Ismill N; Dubé V; Plotkin A; Han G; Cesari M; Lu FI; Saad R; Khalifa M; Nofech-Mozes S
    Int J Gynecol Pathol; 2015 Sep; 34(5):424-36. PubMed ID: 26107560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
    Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
    Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region.
    Pirog EC
    Semin Diagn Pathol; 2015 Sep; 32(5):409-18. PubMed ID: 25862555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions.
    Sun L; Zhang L; Krigman HR; Hagemann IS
    J Low Genit Tract Dis; 2018 Apr; 22(2):104-109. PubMed ID: 29570565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
    Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
    Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
    Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls.
    Angelico G; Santoro A; Inzani F; Straccia P; Spadola S; Arciuolo D; Valente M; D'Alessandris N; Benvenuto R; Travaglino A; Raffone A; Zannoni GF
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33923427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Tyan YS; Kok LF; Yao CC; Wang PH; Hsu JD; Tseng SW
    Virchows Arch; 2009 Oct; 455(4):353-61. PubMed ID: 19763614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.
    Chaux A; Pfannl R; Rodríguez IM; Barreto JE; Velazquez EF; Lezcano C; Piris A; Netto GJ; Cubilla AL
    Am J Surg Pathol; 2011 Apr; 35(4):553-62. PubMed ID: 21399489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
    Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx.
    Jalaly JB; Lewis JS; Collins BT; Wu X; Ma XJ; Luo Y; Bernadt CT
    Cancer Cytopathol; 2015 Dec; 123(12):723-31. PubMed ID: 26242494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial carcinoma involving the gynecologic tract: a morphologic and immunohistochemical study of 6 cases.
    Reyes MC; Park KJ; Lin O; Ioffe O; Isacson C; Soslow RA; Reuter VE; Fine SW
    Am J Surg Pathol; 2012 Jul; 36(7):1058-65. PubMed ID: 22510759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.
    Kaspar HG; Crum CP
    Arch Pathol Lab Med; 2015 Jan; 139(1):39-54. PubMed ID: 25549143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
    Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M
    Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.